3 results match your criteria: "University of Wisconsin Madison Graduate School[Affiliation]"
Health Econ
November 2022
Department Economics, University of Wisconsin Madison Graduate School, Madison, Wisconsin, USA.
This paper estimates the causal effect of the expansion of Colombia's national prescription drug formulary to include five new types of insulin on the healthcare utilization and costs of type I diabetics and explores the mechanisms through which outpatient cost reductions are realized. We find that expanded coverage generates an increase in the cost of insulin for type I diabetics equal to 17% of their baseline healthcare costs. At the same time, their annual outpatient care utilization falls by 1.
View Article and Find Full Text PDFBMJ Open
June 2021
Pharmacy, University of Wisconsin-Madison School of Medicine and Public Health, Madison, Wisconsin, USA.
Introduction: infection (CDI) is one of the most common healthcare-associated infections in the USA, having high incidence in intensive care units (ICU). Antibiotic use increases risk of CDI, with fluoroquinolones (FQs) particularly implicated. In healthcare settings, antibiotic stewardship (AS) and infection control interventions are effective in CDI control, but there is little evidence regarding the most effective AS interventions.
View Article and Find Full Text PDFOchsner J
January 2018
Department of Neurology, University of Wisconsin School of Medicine and Public Health, Madison, WI.
Background: Chronic daily headache, including chronic migraine, can be challenging to treat. Medications often only provide limited improvement, and surgical interventions can be associated with significant adverse effects. We present our experience with using radiofrequency ablation (RFA) for pericranial nerves to treat chronic headache conditions.
View Article and Find Full Text PDF